How to Taper Off Wegovy Safely: The 2026 Prescriber-Ready Plan
Published:
·Last verified: May 22, 2026·Next review: August 2026This page is educational and does not replace a conversation with your prescriber. Not medical advice. Wegovy is a prescription medication.
Here’s the part most pages won’t tell you
There is no official FDA-labeled schedule for how to taper off Wegovy. Novo Nordisk’s prescribing information covers how to start, how to increase the dose, what to do if you miss a shot, and when to stop for pregnancy — but the word “taper” never appears on the label. That doesn’t mean tapering is wrong. It means any taper plan is a clinician judgment call, not a labeled medical procedure.
Fast answer if you’re skimming:
- No official taper schedule exists. Don’t copy a dosing calendar online.
- The right path depends on why you’re stopping — goal weight, side effects, cost, pregnancy, missed doses, or switching.
- Your prescriber will choose: step down, extend intervals, switch forms, stop now, or move you to maintenance.
Build your free Wegovy taper discussion plan (60 seconds)
Answer 8 quick questions — your current dose, why you’re stopping, your refill timing — and get a printable checklist plus a portal-message draft to send your prescriber. No dosing advice. No pressure.
What’s on this page
- What we verified for this page
- Safety information
- Do you have to taper?
- Can you stop cold turkey?
- How long does Wegovy stay in your system?
- Dose strengths to discuss with your prescriber
- When stopping isn't the right move
- 4-Metric Tracker
- Special situations
- How to keep weight off after stopping
- Prescriber conversation script
- What other users are worried about
- Taper readiness score
- FAQ (15 questions)
What we actually verified for this page
| Claim category | What we checked | Date verified |
|---|---|---|
| Wegovy injection doses (0.25, 0.5, 1.0, 1.7, 2.4, 7.2 mg) and tablet doses (1.5, 4, 9, 25 mg) | DailyMed Wegovy prescribing information | May 22, 2026 |
| Wegovy tablet approval and launch | Novo Nordisk press release (FDA approval Dec 22, 2025; US launch early 2026) | May 22, 2026 |
| Wegovy half-life and clearance (5–7 weeks) | DailyMed Wegovy label | May 22, 2026 |
| 2-month pre-pregnancy stop rule | DailyMed Wegovy label | May 22, 2026 |
| Missed-dose restart guidance | DailyMed Wegovy label | May 22, 2026 |
| STEP 1 extension regain data (~two-thirds regain at 12 months) | Wilding et al., Diabetes, Obesity and Metabolism, 2022 | May 22, 2026 |
| Embla 9-week taper data (ECO 2024, n=2,246; 85 with 6-month follow-up) | Gudbergsen et al., European Congress on Obesity 2024 | May 22, 2026 |
| 2024 multi-society GLP-1 + surgery guidance | American Society of Anesthesiologists multi-society statement, October 2024 | May 22, 2026 |
| NovoCare cash-pay pricing (Wegovy injection + tablet) | NovoCare Pharmacy, novocare.com | May 22, 2026 |
| Ro Body membership pricing ($39 first month, $149/mo standard, as low as $74/mo annual) | ro.co/weight-loss/pricing | May 22, 2026 |
If we cite something on this page, it traces back to one of those sources. If we couldn’t verify it, we left it out.
Important safety information — read this first
Do not use Wegovy if:
- You or a family member has a history of medullary thyroid carcinoma (MTC)
- You have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- You’ve had a serious allergic reaction to semaglutide or any other Wegovy ingredient
These are direct from the FDA’s Boxed Warning and Contraindications section of the Wegovy prescribing information. If any of those apply, this taper guide is the wrong page — contact your prescriber today to discuss stopping safely.
Not medical advice. Wegovy is a prescription medication requiring evaluation by a licensed clinician. See our GLP-1 hard contraindications guide for the full list of absolute contraindications.
Do You Have to Taper Off Wegovy?
Answer in 3 sentences
No FDA-labeled taper schedule for Wegovy exists, and the label does not describe dependence-style withdrawal. But stopping is still a real medical decision because pregnancy plans, diabetes medications, severe side effects, missed-dose restart logic, surgery and anesthesia planning, and weight-regain risk can all change the right path. The honest framing is: tapering is optional from a labeling standpoint, but the plan around stopping is not.
If you read a Wegovy taper page that gives you a confident week-by-week schedule without knowing your dose, your insurance situation, whether you’re trying to get pregnant, whether you have type 2 diabetes, whether you’re on insulin, or what your weight has done in the last month — that page is making things up.
The reason isn’t that nobody knows. The reason is that Novo Nordisk never wrote a taper schedule, and clinical trials never tested one. The closest thing we have to evidence is a real-world cohort from the Embla weight-loss app, presented at the 2024 European Congress on Obesity. In that cohort, 2,246 adults used semaglutide alongside coaching, and 353 of them tapered off over an average of about 9 weeks. Of the 85 patients who had 6-month follow-up data after fully stopping, weight stayed stable in the majority — better than the STEP 1 extension data for cold stops. But the Embla sample was small, selected, and measured only at 6 months.
We don’t give you a fake schedule. We give you the questions, the framework, and the monitoring plan your prescriber needs to build a real one.
That’s a better deliverable — because the bottleneck for most people isn’t “what’s the right dose to drop to in week 3.” The bottleneck is walking into the appointment with a plan instead of a hope.
For a broader companion read on what happens once the medication leaves your body, see our piece on what happens when you stop Wegovy.
Start with your real reason for stopping
This is the framework no other taper page builds the page around — and it’s why a “universal Wegovy taper schedule” can’t exist. Five very different people search “how to taper off Wegovy,” and the right answer for each is different.
| Why you’re stopping | The path most likely to work | Things you should NOT do |
|---|---|---|
| Hit your goal weight | Ask your prescriber about labeled maintenance (1.7 mg or 2.4 mg), Wegovy HD if additional weight reduction is clinically indicated, or a clinician-directed off-label lower-dose strategy before stopping completely. | Don't assume reaching goal weight means you no longer need a plan. The STEP 1 extension data is clear on this. |
| Insurance stopped covering it | The fix is usually access, not stopping. Ask your prescriber to support a coverage appeal, switch to the Wegovy tablet at NovoCare cash pricing, or move to another FDA-approved option. | Don't let a coverage problem force an unplanned cold stop. That's the worst-case path for regain. |
| Side effects you can't tolerate | Ask about a step-down to a lower dose, not stopping outright. Most side effects ease at a lower dose. Severe symptoms (see the red-flag list below) mean stop now and call your prescriber. | Don't push through dangerous symptoms. Don't quit a working dose because of mild side effects you haven't discussed. |
| Trying to conceive or already pregnant | The Wegovy label says stop at least 2 months before a planned pregnancy because of the long half-life. This is a stop, not a taper. Talk to your OB and prescriber now. | Don't try to 'ease off' on your own timeline. Don't continue if you may already be pregnant. |
| Missed 2+ doses already | This is not tapering — this is restart logic. The label says your prescriber may need to reinitiate at a lower dose and re-escalate to avoid bad GI side effects. | Don't restart at your old high dose after a long gap. That's a setup for serious nausea, vomiting, and dehydration. |
Find yourself in this table first. Then read the section that matches your row.
Can You Stop Wegovy Cold Turkey?
Answer in 3 sentences
The Wegovy label does not describe dependence-style withdrawal and does not require a taper. But “the label doesn’t require it” is not the same as “stopping abruptly is safe for you” — the answer depends on your reason for stopping, your other medications, pregnancy plans, side effects, missed doses, and follow-up plan.
Stop immediately — don’t taper
- Pregnancy that’s already happened or planned within 2 months
- Severe abdominal pain that could indicate pancreatitis
- Signs of a serious allergic reaction
- Severe vomiting or diarrhea with dehydration
- Surgical or anesthesia situation where your clinical team decided to stop
Abrupt stop is the worse choice here
- You’re at goal weight and want to keep it off
- You’re stopping over cost — the fix is usually switching, not stopping
- You’re tolerating the medication but feeling “done” — there’s usually a smarter middle path
So can you stop cold turkey? Yes, in the sense that there’s no chemical withdrawal. But “can” and “should” are different questions, and the answer to “should” lives in your exam room.
How Long Does Wegovy Stay in Your System After Stopping?
Answer in 3 sentences
Semaglutide has an elimination half-life of about one week, and Wegovy remains in circulation for roughly 5 to 7 weeks after your last 2.4 mg or 7.2 mg injection or 25 mg oral dose, per the FDA label. During that window, appetite suppression fades slowly, then more sharply. Most weight regain happens in months 2 through 12, with the STEP 1 extension reporting that participants regained about two-thirds of their lost weight one year after stopping.
The week-by-week reality after your last dose
| Time after last dose | What’s likely happening | What to watch |
|---|---|---|
| Week 1 | Medication still fully active. You'll feel mostly the same. | Baseline weight, hunger, food noise — write these down |
| Weeks 2–3 | Drug level starting to drop. Most people still feel the appetite effect. | Subtle changes in cravings |
| Weeks 4–5 | Clear shift for many people. Hunger and food noise start coming back. | Daily hunger 1–10, weekly weight, sleep |
| Weeks 5–7 | Drug mostly cleared. The unmedicated baseline returns. | Eating structure, protein, stress |
| Months 2–4 | Weight trend often becomes obvious. This is where regain compounds. | Weekly weight trend, restart threshold |
| Months 4–12 | Without a maintenance system, regain continues. The STEP 1 extension data sits here. | Follow-up appointment, lab markers if relevant |
What the regain data actually shows
STEP 1 extension (Wilding et al., 2022)
After 68 weeks on weekly semaglutide 2.4 mg plus lifestyle support, participants lost about 17.3% of body weight on average. One year after stopping both the medication and the structured lifestyle program, they had regained 11.6 percentage points — about two-thirds of what they lost. They still ended up about 5.6% below their starting weight, on average, but most of the lost weight came back. This is the most-cited number in the tapering literature.
Oxford/BMJ 2026 review on weight regain after stopping GLP-1s
Across many weight-management drugs, average regain was about 0.4 kg per month after stopping. For newer GLP-1s like semaglutide and tirzepatide specifically, regain ran closer to 0.8 kg per month in the studies reviewed.
This isn’t a moral problem. It’s biology. Wegovy works by changing appetite signals while it’s in your body. When the drug leaves, the signals come back. That’s not failure. That’s how the medication works.
Decision Resolution Point #1
If reading this is making you wonder whether stopping is really the goal — that’s a useful instinct. For a lot of readers, the smarter move isn’t tapering at all. It’s switching to a labeled maintenance dose, considering Wegovy HD if more weight loss is clinically indicated, or moving to the Wegovy tablet at NovoCare cash pricing. We cover each below.
Disclosure: The RX Index may earn a commission from Ro links. Medication decisions should be made with your prescriber.
Check FDA-approved Wegovy eligibility through Ro →Ro Body: $39 first month, then as low as $74/month with annual plan paid upfront
Wegovy Dose Strengths Your Prescriber May Discuss
Answer in 3 sentences
When prescribers do step a patient down off Wegovy, the most common pattern is “reverse-titration” — moving back through doses you started on, with each step typically held for at least two weeks before the next change. This is not an FDA-labeled schedule; it’s a clinical pattern your prescriber may or may not use. The doses below exist on the Wegovy label so you can ask informed questions — they are not a do-it-yourself schedule.
Important: Do not use any table on this page as a self-dosing schedule.
The strengths listed are FDA-labeled doses your prescriber may discuss with you. The path that’s safe for you depends on factors only your prescriber can assess.
The Wegovy dose strengths that exist
| Form | Strength | What the label says it’s for |
|---|---|---|
| Injection | 0.25 mg | Starting dose during initial 4-week step-up |
| Injection | 0.5 mg | Escalation dose |
| Injection | 1.0 mg | Escalation dose |
| Injection | 1.7 mg | Labeled adult maintenance option |
| Injection | 2.4 mg | Recommended adult maintenance |
| Injection (Wegovy HD) | 7.2 mg | Higher-dose option after tolerating 2.4 mg for at least 4 weeks, when additional weight reduction is clinically indicated |
| Tablet | 1.5 mg | Starting daily dose |
| Tablet | 4 mg | Escalation |
| Tablet | 9 mg | Escalation |
| Tablet | 25 mg | Recommended adult maintenance |
Two important label rules
- Wegovy tablets must be swallowed whole. Do not split, crush, chew, or dissolve them.
- Wegovy pens are designed for a fixed dose. Do not attempt partial pen dosing without your prescriber.
The discussion to bring to your prescriber
If you and your prescriber decide a step-down makes sense, the common clinical pattern looks like the table below. We’re showing it so you can ask informed questions — not so you can build your own schedule.
| If you’re currently on… | Dose strengths your prescriber may discuss | Time at each step is usually… |
|---|---|---|
| Wegovy HD (7.2 mg) | 7.2 → 2.4 → 1.7 → 1.0 → 0.5 → stop or continue at lower maintenance | At least 2 weeks per step, sometimes longer at 2.4 |
| 2.4 mg | 2.4 → 1.7 → 1.0 → 0.5 → stop or hold | At least 2 weeks per step |
| 1.7 mg | 1.7 → 1.0 → 0.5 → stop | At least 2 weeks per step |
| 1.0 mg | 1.0 → 0.5 → stop | At least 2 weeks per step |
| 0.5 mg | 0.5 → stop, or hold as off-label lower-dose maintenance | A short step or direct stop |
| 25 mg tablet | Lower tablet strengths exist for initiation/escalation, not as a taper schedule | Ask your prescriber — do not lower, split, or improvise tablet dosing |
Bring this table to your appointment. Ask which path fits your reason for stopping. Do not change your dose on your own.
What about spacing out doses instead of stepping down?
Some clinicians may discuss spacing doses farther apart instead of reducing the dose. The 2024 Embla cohort tapered semaglutide over an average of about 9 weeks. We could not verify a published Wegovy-specific interval-spacing calendar, so we’re not going to invent one. If you’re curious whether interval spacing fits your situation, raise it with your prescriber.
Decision Resolution Point #2
Whichever path you and your prescriber choose, the missing piece for most people isn’t the schedule — it’s the monitoring plan that goes around it.
Build my Wegovy taper discussion plan →For Many Readers, the Smarter Move Isn’t Stopping at All
Answer in 3 sentences
Most people who land on a Wegovy taper page assume the goal is to get to zero. The strongest long-term evidence actually points the other way: staying on labeled maintenance (1.7 mg or 2.4 mg) or switching to the new FDA-approved Wegovy tablet preserves more weight loss than stopping completely. For people whose real trigger is cost or insurance, transitioning is usually a better answer than tapering.
Option A: Stay on labeled maintenance
The Wegovy label lists 1.7 mg and 2.4 mg as adult maintenance options, with 2.4 mg as the recommended maintenance dose. Wegovy HD (7.2 mg) is a higher-dose option after tolerating 2.4 mg for at least 4 weeks when additional weight reduction is clinically indicated.
Some clinicians also use off-label lower-dose strategies — continuing on 0.5 mg or 1.0 mg after goal weight — but those strengths are labeled as escalation doses, not labeled maintenance. That conversation belongs in the exam room, not in an article. Many people who came to a taper page leave deciding to stay on a lower labeled maintenance dose instead.
Option B: Switch to the Wegovy tablet
The Wegovy tablet — FDA-approved on December 22, 2025 and launched in the US in early 2026 — is the option that almost no taper page mentions because most were written before it existed. It’s once-daily oral semaglutide at 25 mg. In the OASIS 4 trial, oral semaglutide 25 mg produced 13.6% weight loss in the treatment-policy analysis, with Novo Nordisk reporting 16.6% mean weight loss among adherent participants.
| Product | Dose | Monthly price |
|---|---|---|
| Wegovy tablet | 1.5 mg | $149/month |
| Wegovy tablet | 4 mg | $149/month through Aug 31, 2026, then $199 |
| Wegovy tablet | 9 mg and 25 mg | $299/month |
| Wegovy injection (new self-pay, intro) | 0.25 mg or 0.5 mg | $199/month (first 2 monthly fills, through June 30, 2026) |
| Wegovy injection (standard) | 0.25–2.4 mg | $349/month |
| Wegovy HD injection | 7.2 mg | $399/month |
Per the FDA label: patients on Wegovy 2.4 mg injection once weekly may transition to Wegovy 25 mg tablets once daily one week after discontinuing the 2.4 mg injection. Do not assume this transition applies to Wegovy HD 7.2 mg unless your prescriber confirms.
For people stopping over cost, needle aversion, or travel friction, this one-week bridge is often a better answer than tapering to zero. See our Wegovy pill vs injection comparison.
Option C: Switch to a different GLP-1
If Wegovy plateaued or side effects were limiting, ask your prescriber whether switching to another FDA-approved option — usually Zepbound (tirzepatide) — makes more sense than stopping.
One important safety note
Do not overlap Wegovy with another semaglutide-containing product or any other GLP-1 receptor agonist. The Wegovy label says concomitant use is not recommended. Your prescriber will plan timing between stopping one medication and starting another.
Provider-stated vs verified — what we checked before recommending Ro
| Claim | Source checked | What we verified | Date | Caveat |
|---|---|---|---|---|
| Ro Body membership cost | ro.co/weight-loss/pricing | $39 first month; $149/month standard; as low as $74/month with annual plan paid upfront | May 22, 2026 | Subject to change; medication billed separately |
| Ro Wegovy formulary | ro.co | Carries Wegovy injection, Wegovy tablet, Wegovy HD, Zepbound (pen + KwikPen), Foundayo | May 22, 2026 | Eligibility and state availability vary |
| Ro insurance support | ro.co | Insurance concierge handles prior-authorization paperwork; free GLP-1 Insurance Coverage Checker | May 22, 2026 | Coverage decisions made by insurer |
| Ro + NovoCare pricing relationship | ro.co + novocare.com | Ro integrates with NovoCare Pharmacy; medication price matches NovoCare cash-pay rates | May 22, 2026 | Verify exact prices for your dose |
| Our affiliate relationship | The RX Index | We earn a commission if you sign up through our Ro links | May 22, 2026 | Disclosed inline before every Ro CTA |
Where Ro fits — and the honest caveats you need to hear
For most readers in the situation this page is built for — needing FDA-approved Wegovy, possibly switching to the tablet, possibly needing insurance help — Ro is the cleanest path. Here’s the honest picture:
- Ro carries Wegovy injection, Wegovy tablet, Wegovy HD, Zepbound (pen and KwikPen), and Foundayo
- Ro integrates with Novo Nordisk’s NovoCare Pharmacy, so medication price matches the manufacturer’s transparent cash-pay rates
- Ro’s insurance concierge handles prior-authorization paperwork
- Ro Body membership is $39 for the first month, then as low as $74/month with annual plan paid upfront, or $149/month standard
The damaging admission
Ro is not the cheapest option overall. Some compounded semaglutide programs advertise lower cash prices. But compounded semaglutide is not FDA-approved Wegovy — it’s a separate category with separate pros, cons, and risks. If you’re researching compounded options specifically, our GLP-1 program comparison is built for that decision.
If you’re on this page because you want FDA-approved Wegovy specifically — the cheapest path inside FDA-approved Wegovy is usually the Wegovy tablet through NovoCare or Ro at $149/month for the starting strength.
Decision Resolution Point #3
Stopping Wegovy over cost or coverage is the #1 thing readers describe in patient forums. If that’s you — your insurance just changed, your copay jumped, your refill is due — the next step is almost never “taper to zero.” It’s a 5-minute eligibility check to see whether the Wegovy tablet or labeled maintenance fits your situation.
Disclosure: The RX Index may earn a commission from Ro links. Medication decisions should be made with your prescriber.
Check Wegovy tablet & maintenance eligibility through Ro →For brand-by-brand pricing comparison without committing to anything: our Wegovy Savings Card guide and Best Telehealth for Wegovy comparison.
What to Track Every Week After Your Last Dose
Answer in 3 sentences
Whether you taper, switch, or stop completely, the four signals that matter are appetite, weight trend, food noise, and energy. If any of them shift sharply in the wrong direction for two weeks in a row, your plan is moving too fast — and that’s information your prescriber needs from you the same day, not next month. The point of tracking isn’t to obsess. It’s to catch the slip before it becomes a slide.
The Four Metrics
| What to track | How often | Going well | Call your prescriber |
|---|---|---|---|
| Hunger (1–10 scale) | Once a day, same time | Stable 3–5 | Daily 7+ for a full week |
| Weight | Once a week, same day, same scale, same conditions (morning, after bathroom, before eating) | ±1–2 lb fluctuation | +3 lb/week × 2 consecutive weeks |
| Food noise | Yes/no journal entry, once a day | Mostly quiet | Returned, intrusive, hard to ignore |
| Energy & mood | 1–10, once a week | Stable | Sharp drop, low motivation, sleep disruption |
The early-warning rule
If hunger sits at 7 or higher for a full week, AND your weight trends up for two consecutive weeks — do not push to the next step-down on your own. Contact your prescriber the same day. Ask whether to return to your previous effective dose, pause the taper, switch strategies, or add more support.
There is no prize for finishing a taper on schedule. The prize is keeping the weight off. Many people end up holding at a lower maintenance dose long-term — and that’s a clinically reasonable outcome, not a failure.
The restart threshold conversation
Bring this question to your prescriber word-for-word:
“Before I stop, what weight gain or hunger level would trigger us restarting Wegovy or switching to another medication? I want to know that threshold before I’m in it.”
Knowing the restart line in advance — say, “if I regain 10 lbs, we restart” — removes the panic from the process. It also removes the slow-motion drift where someone regains 30 lbs over six months because they kept telling themselves “I’ll get back on it next month.”
Special Situations — Pregnancy, Surgery, Missed Doses, Insurance Loss
Answer in 3 sentences
Five situations override the normal taper logic and need their own protocol: pregnancy, surgery, sudden insurance loss, missed doses, and severe side effects. In most of these, “tapering” is the wrong frame. The right frame is stop now and call your prescriber — or don’t taper, switch.
Pregnancy or trying to conceive
The Wegovy label says: discontinue Wegovy at least 2 months before a planned pregnancy. This isn’t a clinician recommendation — it’s on the FDA label. The reason is the long half-life of semaglutide. Even after your last shot, the drug stays in circulation for 5–7 weeks. If you may already be pregnant, contact your prescriber today, not next week. This is a stop, not a step-down.
Planned surgery or deep sedation
Wegovy slows how fast your stomach empties, which can be relevant for anesthesia. Current multi-society guidance from the American Society of Anesthesiologists and partner organizations (October 2024) shifted away from the older 2023 “hold for 7 days” rule. Most patients can continue their GLP-1 medication before elective surgery. Higher-risk patients may need individualized precautions.
Tell your surgeon, your anesthesia team, and the prescriber managing your Wegovy at least two weeks before any planned procedure. They make the call together — not you, not us, not an article.
Insurance just stopped covering it
Don’t taper to zero because of paperwork. The first move is to keep options open:
- Ask your prescriber whether they can submit an appeal or letter of medical necessity to your insurer.
- Ask whether the Wegovy Savings Card is now your best path — see our savings card guide for current eligibility.
- Compare cash-pay FDA-approved options — primarily the Wegovy tablet through NovoCare Pharmacy or Ro starting at $149/month for the 1.5 mg strength.
- If none of those fit, then talk through a structured stop with your prescriber, not an abrupt one driven by a missed refill date.
Missed 2+ Wegovy doses
If you’ve already been off Wegovy for two or more weeks, you’re not tapering — you’re in restart territory. Per the label, when 2+ consecutive injection doses are missed, your prescriber may either (a) resume your schedule if not too much time has passed, or (b) reinitiate at a lower dose and re-escalate to prevent severe GI side effects. Do not jump back on your old high dose after a gap.
For missed Wegovy tablets, the label is simpler: skip the missed dose and take the next dose the following day. Do not double up.
Severe side effects — the red-flag list
These are not “step down and see” situations. These are “stop, call your prescriber today, or go to urgent care” situations:
| Symptom | What it could mean | Action |
|---|---|---|
| Severe, persistent abdominal pain (sometimes radiating to back) | Possible pancreatitis (label warning) | Stop Wegovy; contact prescriber urgently or go to ER |
| Repeated vomiting, diarrhea, or signs of dehydration | Kidney injury risk (label warning) | Stop; hydrate; contact prescriber |
| Right-upper-abdominal pain, fever, yellowing of skin or eyes | Possible gallbladder issue (label warning) | Stop; contact prescriber today |
| Symptoms of low blood sugar (if also on insulin or sulfonylurea) | Hypoglycemia (label warning) | Treat low immediately; contact prescriber for medication adjustment |
| Swelling, breathing trouble, severe rash | Possible hypersensitivity reaction (label warning) | Stop; seek urgent care |
| Vision changes (if you have diabetic retinopathy) | Diabetic retinopathy progression risk noted in label | Stop; contact your eye doctor and prescriber |
These are from the Wegovy prescribing information’s warnings and precautions section. Not a complete list. See our GLP-1 safety guide for a full picture.
How to Keep the Weight Off After Your Last Dose
Answer in 3 sentences
The factors that consistently separate people who hold their weight from people who regain are structural, not motivational: enough protein, resistance training, sleep, a real meal cadence, and a willingness to step back onto medication if the numbers go in the wrong direction. None of this is exciting. All of it is what works.
The first 8 weeks after your last dose
This window is fragile because the medication is still leaving your system. Make these the eight non-negotiable weeks:
Schedule a follow-up appointment. With your prescriber for week 6–8 before you stop. Don't leave it to 'I'll call when I need to.'
Get protein at every meal. Ask your prescriber or a registered dietitian what daily protein target fits your body size, kidney function, and medical history. Don't pull a gram-per-kg number from the internet.
Train at least two days a week with resistance. During and after weight loss, you lose some lean mass. Holding onto it makes everything else easier. Lifting, resistance bands, bodyweight, kettlebells — pick one and do it.
Protect your sleep. Poor sleep makes appetite control harder. Build sleep into your maintenance plan, not as an afterthought.
Weigh weekly, not daily. Daily weight is noise. Weekly trend is signal.
Don't restart the bad cadence. Skipping breakfast, eating one big late meal, drinking your calories — the patterns that pre-date Wegovy will reassert themselves unless you replace them.
What “success” should actually look like
If you stop Wegovy and regain zero pounds, that’s wonderful — and not what the data predicts for most people. A more realistic definition of success after stopping:
- You regain less than the published average (less than 11–12 percentage points at 12 months)
- You catch the regain before it accelerates
- You and your prescriber have a clear restart threshold
- Your cardiometabolic markers stay closer to where they ended up while on treatment than to where they started
That’s a win. That’s the real goal.
Your Prescriber Conversation Script
Answer in 3 sentences
The single highest-leverage thing you can do before stopping Wegovy is walk into the appointment with specific questions instead of a general “I want off.” The script below is what we’d bring if it were us. Print it, write your answers in the margins, take it with you.
The 10 questions to ask your prescriber
Print this. Fill it in. Bring it.
- Q1. What is my main reason for stopping, and does it actually require stopping?
- Q2. Given that reason, do I need to stop now, step down, extend the interval, switch to the tablet, stay on labeled maintenance, or consider Wegovy HD?
- Q3. If we step down, which doses, in what order, and how long at each step?
- Q4. What signs would tell us the step-down is moving too fast?
- Q5. What weight gain, hunger level, or symptom would trigger going back up or restarting?
- Q6. If insurance is the reason — can you help with appeal paperwork, or should we switch to the Wegovy tablet through NovoCare?
- Q7. If I'm planning pregnancy, what's my exact stop date relative to when we're trying to conceive?
- Q8. If I have type 2 diabetes — do any of my other medications need to change as we stop Wegovy?
- Q9. Should I have surgery, anesthesia, or any procedure in the next 3 months that we need to plan around?
- Q10. When's my next follow-up, and what should I track between now and then?
A portal message you can copy
Most prescribers prefer a structured message in their portal over a phone call. Here’s a template — fill in the blanks:
That message takes 90 seconds to send and saves an appointment cycle.
Decision Resolution Point #4
If you’ve read this far, the real next step is sending a message to your prescriber. Our planner tool builds you a personalized version of the message above based on your exact dose and reason for stopping — plus a printable plan for the appointment itself.
Generate my personalized prescriber message →What Other Wegovy Users Are Actually Worried About
We pulled the most common patient-forum phrasing from r/WegovyWeightLoss and similar public threads — not as medical evidence, just so you know you’re not alone. These are real things real people wrote in 2025–2026:
Hit goal weight. Should I taper off or just stop cold turkey?
The food noise comes back so quickly. Is that real or am I imagining it?
I'm worried I won't be able to find the lower doses to taper down with — what if my pharmacy doesn't carry 0.5 anymore?
Are there real dangers of stopping cold turkey? Like withdrawal?
My insurance just dropped coverage and my refill is due in 9 days. I'm panicking.
I want to get pregnant. My doctor said 'just stop' but didn't give me a date.
A few quick reassurances based on the verified label and evidence
- Wegovy is not a controlled substance and is not described in the label as causing dependence-style withdrawal. What returns is appetite and food noise — uncomfortable, but not a chemical withdrawal syndrome.
- The lower-dose pens exist as labeled strengths. Local pharmacy stock can still vary, so ask your prescriber or pharmacy before building your plan around a specific lower dose.
- Insurance-driven stops are common. Ask your prescriber about appeal paperwork, continuation-of-care documentation, or an access bridge before you stop.
- Pregnancy timing has a specific label answer: 2 months before conception. Get that on the calendar.
Wegovy Taper Readiness Score
Answer in 3 sentences
Even if you’re confident you want to stop Wegovy, “wanting to stop” is not the same as “ready to stop safely.” Below is our 12-point readiness check — score yourself before you change anything. If you’re below 9 points, you’ve found gaps to close before the medication change, not after.
Score each item 0–2 (0 = no, 1 = partly, 2 = yes):
| # | Question | Your score |
|---|---|---|
| 1 | I have a clear, written reason for stopping. | __ |
| 2 | I have an appointment or portal message scheduled with my prescriber. | __ |
| 3 | I know my current dose and how long I've been on it. | __ |
| 4 | I know my weight trend over the last 4 weeks. | __ |
| 5 | I have a plan for what to eat when hunger comes back. | __ |
| 6 | I have a protein, fiber, and meal-cadence plan. | __ |
| 7 | I have a resistance training or strength routine I actually do. | __ |
| 8 | I've reviewed the red-flag symptom list with my prescriber or read it carefully. | __ |
| 9 | I've checked for pregnancy plans, surgery plans, and any diabetes medications that might need adjustment. | __ |
| 10 | I have a backup plan if my insurance changes or my refill schedule slips. | __ |
| 11 | I have a defined restart threshold (weight gain / hunger level) with my prescriber. | __ |
| 12 | I have a follow-up appointment scheduled within 8 weeks of stopping. | __ |
Add them up
| Score | What it means | What to do next |
|---|---|---|
| 0–8 | You’re not ready yet — and that’s fine. | Close the gaps before any dose change. Use our planner. |
| 9–16 | You’re partially ready. | Identify your lowest-scored items and fix them before the appointment. |
| 17–24 | You’re well-prepared. | Schedule the conversation and bring this page with you. |
Frequently Asked Questions About How to Taper Off Wegovy
Is there an official Wegovy taper schedule?
No. The current Wegovy prescribing information includes detailed instructions for starting, escalating, switching between forms, handling missed doses, and stopping for pregnancy — but no formal taper schedule. Any step-down plan is a clinician judgment call, not an FDA-labeled procedure.
Do you have to taper off Wegovy?
No FDA-labeled taper is required, and the Wegovy label does not describe dependence-style withdrawal. But stopping is still a real medical decision because pregnancy plans, diabetes medications, severe side effects, missed-dose restart, surgery and anesthesia planning, and weight-regain risk can all change the plan.
Can you stop Wegovy cold turkey?
The Wegovy label does not describe dependence-style withdrawal or require a labeled taper. But whether stopping suddenly is safe for you depends on why you are stopping, your other medications, pregnancy plans, side effects, missed doses, and follow-up plan. Talk to your prescriber before stopping suddenly.
How long does Wegovy stay in your system after stopping?
Semaglutide has an elimination half-life of about one week. Wegovy remains in circulation for roughly 5 to 7 weeks after your last 2.4 mg or 7.2 mg injection or 25 mg oral dose, per the FDA label. That's why stopping doesn't feel sudden — appetite and food noise typically return gradually over the first 4–6 weeks, then more sharply.
How long does it take to taper off Wegovy?
There is no labeled answer. The 2024 Embla real-world cohort averaged about 9 weeks to fully taper. Your prescriber may go faster or slower based on your situation. Do not build your own schedule from internet examples.
Will I gain weight back after stopping Wegovy?
Probably some. The STEP 1 extension trial showed participants regained about two-thirds of their lost weight one year after stopping semaglutide 2.4 mg and the structured lifestyle program. A maintenance plan including protein, resistance training, sleep, and a defined restart threshold can reduce regain in many people.
Can I take Wegovy every other week to taper?
Some clinicians may discuss spacing doses farther apart instead of stepping the dose down. It is not an FDA-labeled approach, and there is no published Wegovy-specific spacing calendar. If you are curious, raise it with your prescriber — do not start spacing doses on your own.
Can I split a Wegovy tablet to taper?
No. The Wegovy tablet label is explicit: swallow whole. Do not split, crush, chew, or dissolve. Splitting can disrupt the absorption-enhancing technology that makes oral semaglutide work.
Can I take a half-dose from a Wegovy pen?
Do not try this on your own. Wegovy pens are prefilled single-dose devices. Anything that involves manipulating the pen dose without your prescriber and the product instructions specifically supporting it is off-label and potentially unsafe.
What if I missed two or more Wegovy doses?
Per the Wegovy label, your prescriber may resume your schedule if not too much time has passed, or reinitiate at a lower dose and re-escalate to avoid severe GI side effects. Do not restart at your previous high dose after a long gap. Contact your prescriber.
When should I stop Wegovy before pregnancy?
The Wegovy label says to discontinue Wegovy at least 2 months before a planned pregnancy because of semaglutide's long half-life. Anyone who becomes pregnant while taking Wegovy should contact their prescriber and OB right away.
Can I switch from Wegovy injection to the Wegovy tablet instead of tapering?
Yes. Per the FDA label, patients on Wegovy 2.4 mg injection once weekly may transition to Wegovy 25 mg tablets once daily one week after discontinuing the 2.4 mg injection. Do not assume the same one-week transition applies if you are on Wegovy HD 7.2 mg — confirm with your prescriber.
Can I restart Wegovy if I regain weight after stopping?
Yes. Most prescribers re-initiate Wegovy at a lower starting dose, typically 0.25 or 0.5 mg, and titrate back up over about 16 to 20 weeks, similar to the original escalation.
Should I switch to a different GLP-1 instead of stopping?
If Wegovy plateaued or side effects were limiting, ask your prescriber whether switching to another FDA-approved option like Zepbound makes more sense than stopping. Do not overlap GLP-1 medications on your own — the Wegovy label says concomitant use with other semaglutide-containing products or any GLP-1 receptor agonist is not recommended.
What's the absolute first thing I should do before stopping Wegovy?
Send your prescriber a portal message with your dose, reason for stopping, weight trend, and any other situational factors. Do not change your dose first. Do not let your next refill expire first. Message first.
Still not sure which path is right for you?
Take our free 60-second GLP-1 path quiz. We’ll help you compare FDA-approved access paths, insurance support options, and whether tapering, maintenance, or switching fits your situation. No pressure. No upsell. Just a personalized action plan.
Take the GLP-1 path quiz →About this page
The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. We verify pricing, FDA approval status, formulary, and policy details for every provider we cover. We may earn an affiliate commission if you use certain provider links (including Ro), and we disclose that inline before every commercial CTA on this page.
We built this page as a medical-safety guide first and a commercial page second. If you removed every CTA, the prescriber script, readiness score, 4-metric tracker, and verified-source table would still be the value we built before adding any commercial links.
Sources verified for this page
- FDA Wegovy prescribing information (DailyMed): injection 0.25 / 0.5 / 1.0 / 1.7 / 2.4 / 7.2 mg and tablet 1.5 / 4 / 9 / 25 mg labels
- Novo Nordisk press release announcing FDA approval of Wegovy tablets, December 22, 2025
- Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism. 2022;24(8):1553–1564.
- Gudbergsen H et al. Tapering semaglutide presentation, European Congress on Obesity 2024 (Embla cohort, n=2,246)
- Oxford/BMJ 2026 review on weight regain after stopping weight-management drugs
- American Society of Anesthesiologists multi-society guidance on perioperative GLP-1 management, October 2024
- NovoCare Pharmacy cash-pay pricing for Wegovy injection and Wegovy tablet
- Ro Body membership pricing and Wegovy formulary (ro.co/weight-loss/pricing)
Authorship: Written and reviewed by The RX Index Editorial Team. We do not list a clinical reviewer because no clinician with verifiable credentials reviewed this specific page. If that changes, we’ll update this section with the reviewer’s name, credentials, and review date.
Affiliate disclosure: Some links on this page are sponsored. We may earn a commission if you use them, at no extra cost to you. This does not affect editorial recommendations.